ASX:OPL

Opyl Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

VolumeN/A

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive OPL News and Ratings via Email

Sign-up to receive the latest news and ratings for Opyl and its competitors with MarketBeat's FREE daily newsletter.

About Opyl

Opyl Limited operates a SaaS platform that allows to search and source user generated content (UGC). Its UGC Discovery platform protects against unauthorized use of people's social and digital content. The company also offers social media marketing agency services, including client and account management services; a MediaConsent Clinical platform that aggregates structured and unstructured data from various sources giving consumers or patients control over their health data and to contribute their data to medical research; and consumer data and privacy compliance services. It operates in Australia and the United States. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.

Those Who Purchased Opyl (ASX:OPL) Shares Three Years Ago Have A 85% Loss To Show For It
July 6, 2020 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Health Information Services
Sub-IndustryN/A
SectorMedical
Current SymbolASX:OPL
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.opyl.ai
Phone61 3 9923 1222
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$741,494.00
Price / Sales0.00
Cash FlowN/A
Price / Cash FlowN/A
Book ValueA$0.02 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Opyl.

0.0 Community Rank

Outperform Votes
Opyl has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Opyl has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Opyl and other stocks. Vote “Outperform” if you believe OPL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OPL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Opyl does not currently pay a dividend.
Dividend Growth
Opyl does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Opyl insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Opyl (ASX:OPL) Frequently Asked Questions

What stocks does MarketBeat like better than Opyl?

Wall Street analysts have given Opyl a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Opyl wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Opyl's key executives?

Opyl's management team includes the following people:

Ms. Michelle Gallaher, Chief Exec. Officer
Mr. Damon Rasheed, Exec. Director
Mr. Shane Lewis, VP of Sales & Partnerships
Mr. Scott Sorochak, Chief Revenue Officer
Mr. Jason Weaver, Chief Product Officer & Advisor
Mr. David Lilja M.B.A., Company Sec.

Who are some of Opyl's key competitors?

Some companies that are related to Opyl include 1st Group (1ST), Alcidion Group (ALC), Binovi Technologies (BNVIF), Cann American (CNNA), Carebook Technologies (CRBKF), CloudMD Software & Services (DOCRF), Cogstate (CGS), Corum Group (COO), EGF Theramed Health (EVAHF), Emyria (EMD), eWellness Healthcare (EWLL), Global Health (GLH), ICS Global (ICS), Intelicare (ICR) and Jayex Healthcare (JHL).
View all of OPL's competitors.

What is Opyl's stock symbol?

Opyl trades on the ASX under the ticker symbol "OPL."

How much money does Opyl make?

Opyl has a market capitalization of $0.00 and generates $741,494.00 in revenue each year.

What is Opyl's official website?

The official website for Opyl is www.opyl.ai.

How can I contact Opyl?

The company can be reached via phone at 61 3 9923 1222.

This page was last updated on 7/28/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.